For the year ending 2025-12-31, STOK has $418,434K in assets. $65,977K in debts. $84,220K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 84,220 | |||
| Marketable securities - short term | 200,450 | |||
| Accounts receivable | 5,936 | |||
| Prepaid expenses | 8,736 | |||
| Other current assets | 3,895 | |||
| Restricted cash - short term | 494 | |||
| Interest receivable | 1,969 | |||
| Total current assets | 305,700 | |||
| Restricted cash - long term | 227 | |||
| Operating lease right-of-use assets | 3,101 | |||
| Marketable securities - long term | 106,260 | |||
| Property, and equipment, gross | 13,292 | |||
| Less accumulated depreciation | 10,146 | |||
| Property and equipment, net | 3,146 | |||
| Total assets | 418,434 | |||
| Accounts payable | 4,939 | |||
| Accrued and other current liabilities | 41,035 | |||
| Deferred revenue - current portion | 11,901 | |||
| Total current liabilities | 57,875 | |||
| Deferred revenue - net of current portion | 6,961 | |||
| Other long term liabilities | 1,141 | |||
| Total long term liabilities | 8,102 | |||
| Total liabilities | 65,977 | |||
| Common stock, par value of 0.0001 per share 300,000,000 shares authorized, 58,921,999 and 54,032,826 shares issued and outstanding as of december 31, 2025 and 2024, respectively | 5 | |||
| Additional paid-in capital | 849,624 | |||
| Accumulated other comprehensive income (loss) | 543 | |||
| Accumulated deficit | -497,715 | |||
| Total stockholders equity | 352,457 | |||
| Total liabilities and stockholders equity | 418,434 | |||
Stoke Therapeutics, Inc. (STOK)
Stoke Therapeutics, Inc. (STOK)